Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 2, 2000, Pages 66-69

  Moore, P Brian ^a   Day, J Philip ^b   Taylor, Geoffrey A ^a   Ferrier, I Nicol ^a   Fifield, L Keith ^b   Edwardson, James A ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Accelerator mass spectrometry; Aluminium, isotopic; Alzheimer's disease; Gastrointestinal absorption

Indexed keywords

ALUMINUM; TRACER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; MALE; MASS SPECTROMETRY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE;

EID: 0033998274     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017216     Document Type: Article

References (25)

1. Yanker BA: Review: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996;16:921-932.
2. St George-Hyslop PH: The molecular genetics of Alzheimer's disease; in Terry RD, Katzman R, Bick KL (eds): Alzheimer's Disease. New York, Raven Press, 1994, pp 345-352.
3. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-McLachlan DR, Alberts MS, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-1472.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;324:697-699.
5. Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L: Alzheimer's disease in Finnish twins. Lancet 1996;347:573-578.
6. Doll R: Review: Alzheimer's disease and environmental aluminium. Age Ageing 1993;22: 138-153.
7. Rifat AL: Aluminium hypothesis lives. Lancet 1994;343:3-4.
8. Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA: Aluminosilicate and senile plaque formation in Alzheimer's disease. Lancet 1986;i:345-356.
9. 67Gallium as a potential marker for aluminium transport in rat brain: Implications for Alzheimer's disease. J Neurochem 1990;55:251-259.
10. Morris CM, Candy JM, Oakley AE, Taylor G, Mountfort S, Bishop H, Ward MK, Bloxham CA, Edwardson JA: Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J Neurol Sci 1989;94:295-306.
11. Candy JM, McArthur FK, Oakley AE, Taylor GA, Chen CPLH, Mountfort SA, Thompson JE, Chalker PR, Bishop HE, Beyreuther K, Perry G, Ward MK, Martyn CN, Edwardson JA: Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci 1992;107:210-218.
12. Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM: Alzheimer's disease-like changes in tau protein processing: Association with aluminium accumulation in brains of renal dialysis patients. Lancet 1994;343:993-997.
13. Martyn C, Osmond C, Edwardson JA, Barker DJP, Harris EC, Lacey RF: Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet 1989;i:59-62.
14. McLachlan DRC, Bergeron C, Smith JE, Boomer D, Rifat SL: Risk for neuropathologically confirmed Alzheimer's disease and residual aluminium in municipal drinking water employing weighted residential histories. Neurology 1996;46:401-405.
15. Weberg R, Berstad A: Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. Eur J Clin Invest 1986;16:428-432.
16. Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, Edwardson JA: Gastrointestinal absorption of aluminium in Alzheimer's disease: Response to aluminium citrate. Age Ageing 1992;21:81-90.
17. Moore PB, Edwardson JA, Ferrier IN, Taylor GA, Lett D, Tyrer SP, Day JP, King SJ, Lilley JS: Gastrointestinal absorption of aluminium is increased in Down's syndrome. Biol Psychiatry 1997;41:488-492.
18. King SJ, Oldham C, Popplewell JF, Carling RS, Day JP, Fifield LK: Determination of uluminium-26 in biological materials by accelerator mass spectrometry. Analyst 1997;122:1049-1055.
19. 26Al accelerator mass spectrometry. Nucl Instr Methods Phys Res 1994; B92:469-472.
20. Edwardson JA, Moore PB, Ferrier IN, Lilley JS, Newton GWA, Barker J, Templar J, Day JP: Effect of silicon on gastrointestinal absorption of aluminium. Lancet 1993;342:211-212.
21. American Psychiatric Association: Diagnostic and Statistical Manual, ed 3, revised. Washington, APA, 1987.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
23. Moore PB, Edwardson JA, Ferrier IN, Taylor GA, Lett DJ, Tyrer SP, King SJ, Lilley JS, Day JP: Gastrointestinal absorption of aluminium is increased in Down's syndrome and Alzheimer's disease. Dev Brain Dysfunct 1994;7: 253.
24. Tanzi RF, Gusella JF, Watkins PC, Bruns GAP, St George-Hyslop P, Van Keuren ML. Patterson D, Pagan S, Kurnitt DM, Neve RL: Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987;235:880-884.
25. Froment DPH, Molitoris BA, Buddington B, Miller N, Alfrey AC: Site and mechanism of enhanced gastrointestinal absorption of aluminium by citrate. Kidney Int 1989;36:978-984.